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390* Improving clinic attendance
J.K. Walker1, F. Edenborough1, M. Wildman1, Z. Perveen1, Y. Locke1. 1Adult
Cystic Fibrosis Centre, Shefﬁeld Teaching Hospitals NHS Foundation Trust,
Shefﬁeld, United Kingdom
Aims: Non-attendance at clinics is a common problem among adult Cystic Fibrosis
(CF) patients and may result in incomplete monitoring and poor adherence to
treatment. The Adult Cystic Fibrosis Centre at Shefﬁeld’s Northern General Hospital
had 104 clinic appointments which patients failed to attend (DNAs) in the 9 months
between January and September 2007. This averaged 11 DNAs per month. We
decided to trial telephone reminders in an attempt to reduce the DNA rate.
Methods: A support worker (ZH) was employed to phone patients one or two
working days before they were booked for clinic and either remind them directly of
their appointments or leave a message. We then counted the number of attendees
and DNAs and compared results for the same months the previous year.
Results: In seven weeks of November and December 2006, without telephone
reminders, there were 111 clinic appointments booked and 21 DNAs, DNA rate
18.9% (95%CI 12.4−27%). In the corresponding 7 weeks in 2007, after tele-
phone contacting was introduced, there were 199 clinic appointments booked and
15 DNAs, DNA rate 7.5% (95%CI 4.4−11.9%), c2 = 8.992, p = 0.003.
All those who DNAd despite the telephone call service, were not contactable or
had to have a message left on their phone.
Conclusions: Contacting adults with CF the day before their clinic appointment
is an effective, low-cost, time-efﬁcient method of improving clinic attendance.
Speaking to patients directly is far more effective than leaving a message. An
automated text messaging service might be a more economical alternative that
requires further assessment.
Clinic appointments DNAs DNA rate
Without telephone reminder 111 21 18.9%
With telephone reminder 199 15 7.5%
391* Concordance and perceived beneﬁts in patients with
cystic ﬁbrosis using dossett boxes
M.E. Williams-Gunn1, J. Keane1, M. Butler1, L.M. Kuitert1. 1Adult Cystic
Fibrosis Service, Barts and The London NHS Trust, London, United Kingdom
Introduction: In chronic illness concordance with treatment is recognised to fall
with increasing complexity of medications and frequency of dosing1. Self reported
concordance with medication, both oral and nebulised, is poor in cystic ﬁbrosis
(CF). We introduced medication dossett boxes (similar to those used by the elderly)
in an attempt to improve concordance.
Aim: To assess the impact of dossett boxes on self reported concordance in adults
with CF.
Method: Patients reporting poor concordance with therapies were offered a dossett
box. They were required to ﬁll the box weekly. Patients agreeing to use a dossett
box were sent an adapted CF quality of life (QoL) questionnaire at least one month
after starting to use the box, to assess the impact of its use.
Results: 16 patients with poor concordance were identiﬁed and began using a
dossett box. Each was sent the adapted postal questionnaire; 12 (75%) were
completed. All 12 patients (100%) reported an increase in their concordance and
perceived an improvement in their health status. All strongly agreed with the
statement that their dossett box saved them time. Interestingly, although the dossett
box was for oral medications only, 7 patients (58%) felt it helped them to remember
to take their nebulised drugs. All patients were enthusiastic about the beneﬁt of
dossett boxes and were recommending it to other CF patients at our Centre. While
the numbers are small, clinical stability, lung function and fat soluble vitamin levels
appear to have improved in these patients, although longer follow up is required to
conﬁrm these ﬁndings.
Conclusion: Dossett boxes can help improve concordance with treatments in CF
and potentially improve health status.
Reference(s)
[1] Tashkin DP. Chest 1995;107:176S.
392* An experiential approach to understanding adherence in CF
B. Ashby1, J. Pagan1, K. Lamballe1, D. Beeforth1, P. Cole1, S. Earnshaw1,
F. Hampton1, J. Higgins1, F. Lindsay1, S. Robson1, P. Singleton1, R. Weatherall1.
1Teesside CF Service, Middlesbrough, United Kingdom
Background: The paediatric CF team in Teesside decided to experience ﬁrst hand
a prescribed medical regime.
Aim: To determine how this experience might inﬂuence the team’s approach to
problems with adherence being encountered in clinic.
Method: Ten team members took part over a six-week period. Each had tasks
representing physiotherapy, exercise, diet and medical treatment. Adherence was
recorded daily, with personal reﬂections during and after the challenge.
Results: Adherence for all tasks ranged from 45% to 96% with 6 individuals
achieving 75% or above. 73% of physiotherapy and exercise tasks, 75% of
medical treatments and 90% of dietary tasks were completed. Most participants
acknowledged feeling resentful on occasions and some lost their initial motivation.
In week 1 93.4% of tasks were completed but in week 6 this fell to 65.5%.
Reﬂections:Most individuals achieved fair adherence rates but this was an artiﬁcial
task carried out by people in good health for a limited period. All team members feel
they have learned from the ways they coped with their own difﬁculties in adherence.
Ensuing team discussions centred around deﬁning and adjusting our expectations of
individuals and their different treatments at various stages in their disease. Particular
emphasis has been on those coping with the challenges of adolescence as well as CF.
Changes in practice include exploring practical ways of making tasks more palatable
through being ﬂexible and discussing options for compromise while recognising the
emotions evoked by difﬁculties in adherence. Alongside this the team appreciates
that most patients do well most of the time with the demands of their treatments
and that signiﬁcantly reduced adherence might compromise life expectancy.
393 Adherence to nebulised antibiotics in cystic ﬁbrosis
G. Latchford1,2, A. Duff2, J. Quinn1, S. Conway2, M. Conner3. 1Leeds Institute
of Health Sciences, University of Leeds, Leeds, United Kingdom; 2Adult CF Unit,
Seacroft Hospital, Leeds, United Kingdom; 3Institute of Psychological Sciences,
University of Leeds, Leeds, United Kingdom
Objective: To examine the adherence of patients with Cystic Fibrosis to nebulised
antibiotics.
Methods: A longitudinal design with adherence data collected over 12 weeks.
38 patients (mean age 24.6 years, sd 5.3) were recruited from an adult CF clinic.
Adherence was electronically monitored using a Prodose Adaptive Aerosol Delivery
(AAD) device.
Results: Three indices of adherence were calculated: Mean percentage of times
the nebuliser was used as prescribed was 50.0% (sd = 39.7, range 1.1, 155.6);
mean percentage of days fully adhered was 31.6% (sd = 29.4, range 0, 97.2);
mean percentage of days nebuliser used at least once was 57.1% (sd = 34.2, range
3.3, 100).
Conclusion: Rates of adherence were generally low. Adherence was not associated
with any variables apart from age. There were wide variations between individuals,
and signiﬁcant differences in rates of adherence depending on how this was deﬁned.
Practice implications: CF teams need to be mindful of the pattern of non-adherence
for each individual. In particular, CF teams need to be aware that the advantages
of the next generation nebuliser devices do not necessarily translate into optimal
patterns of adherence. Attention needs to be given to methods of educating patients
about the new devices that lead to improvements in nebuliser technique and
adherence behaviour. Interestingly, the chip in the devices offers the prospect of
providing patients with detailed personalised feedback on their nebuliser use. As
part of a broader psychoeducation strategy within a framework such as motivational
interviewing, such feedback could be a signiﬁcant factor in highlighting a need for
change and ﬁne tuning behaviour.
